Rev Esp Quimioter 2021;34(Suppl.1):69-71

Respiratory co-and superinfections in COVID-19


Published: 30 September 2021


There are few publications on the impact of coinfection and superinfection in patients with COVID-19. Patients with higher severity are much more prone to secondary bacterial, fungal or viral infections. The overuse of antimicrobials in many viral infections (including SARS-CoV-2 infections) undoubtedly contributes to the current antimicrobial resistance crisis. In the context of COVID-19, we are witnessing an increase in multidrug-resistant bacterial infections in our hospitals. The heterogeneity of published studies makes it critical to perform more large-scale studies to better understand the pathogenesis of coinfections or superinfections in the COVID-19 patient.

Rev Esp Quimioter 2021; 34(Suppl. 1):69-71 [Full-text PDF]